The TherapySelector app supports you as a doctor to easily and quickly choose a data-based, personalized treatment for hepatitis C for and with your patient during consultation hours.
The app shows in a single glance information about the effectiveness of medication based on the cure rate for the hepatitis C infection, the likelihood of adverse events, cost and patient group size. This overview allows you to easily and quickly decide on the best personalized treatment method for your patient, based on up-to-date study data.
How does TherapySelector work?
First you enter the four requested characteristics of your patient by answering 4 simple questions about etiology, disease stage, previous treatments and comorbidities. Based on this, a profile of the patient is determined. The app then shows an overview of all registered treatments for that specific patient profile, based on monthly updated study results. For each therapy you find information about effectiveness, possible adverse events and costs.
The TherapySelector app currently provides the following features:
• Determination of patient profiles based on four simple questions about the patient
• Probability of "success" of all registered medication (combinations) for hepatitis C, together with the probability of adverse events associated with the patient profile
• Detail information, including information about dosage and the cost of a specific treatment.
• Monthly import of data from scientific studies, or at least once per quarter.
• Availability in both English and Dutch.
TherapySelector is intended to provide physicians and patients up-to-date and personalized information to support them in choosing the most appropriate treatment. In doing so, the app complements guidelines that are often not up-to-date and are based on the ‘average’ patient.
Developed with (academic) medical centers and research institutes
The app has been developed by TherapySelector in collaboration with physicians and scientists associated with universities and leading academic medical centers such as the Erasmus MC, LUMC and MUMC+. The data in the app has been authorized by specialists from Dutch scientific associations.
The results in the app are calculated using anonymous patient data from scientific studies of published randomized controlled trials, other phase 2 & 3 studies and prospective real-life studies around the world (high quality research). Research groups and sponsors make their data available for this purpose.
Monthly updates
We regularly make changes to the TherapySelector app. On a monthly basis we import new data.
About TherapySelector
TherapySelector B.V. is a social enterprise. Our mission is to improve health care globally by enriching it with personalized treatment information based on the most recent data from scientific studies. It is not our goal to make profit.
With the TherapySelector app, we facilitate doctors with personalized care to achieve health gains for their patients. Additionally, we want to aid in controlling the rising costs of healthcare for the public, e.g. by preventing over- and under-treatment.
Follow us on LinkedIn (https://www.linkedin.com/company/therapyselector) or visit www.therapyselector.nl.
The app shows in a single glance information about the effectiveness of medication based on the cure rate for the hepatitis C infection, the likelihood of adverse events, cost and patient group size. This overview allows you to easily and quickly decide on the best personalized treatment method for your patient, based on up-to-date study data.
How does TherapySelector work?
First you enter the four requested characteristics of your patient by answering 4 simple questions about etiology, disease stage, previous treatments and comorbidities. Based on this, a profile of the patient is determined. The app then shows an overview of all registered treatments for that specific patient profile, based on monthly updated study results. For each therapy you find information about effectiveness, possible adverse events and costs.
The TherapySelector app currently provides the following features:
• Determination of patient profiles based on four simple questions about the patient
• Probability of "success" of all registered medication (combinations) for hepatitis C, together with the probability of adverse events associated with the patient profile
• Detail information, including information about dosage and the cost of a specific treatment.
• Monthly import of data from scientific studies, or at least once per quarter.
• Availability in both English and Dutch.
TherapySelector is intended to provide physicians and patients up-to-date and personalized information to support them in choosing the most appropriate treatment. In doing so, the app complements guidelines that are often not up-to-date and are based on the ‘average’ patient.
Developed with (academic) medical centers and research institutes
The app has been developed by TherapySelector in collaboration with physicians and scientists associated with universities and leading academic medical centers such as the Erasmus MC, LUMC and MUMC+. The data in the app has been authorized by specialists from Dutch scientific associations.
The results in the app are calculated using anonymous patient data from scientific studies of published randomized controlled trials, other phase 2 & 3 studies and prospective real-life studies around the world (high quality research). Research groups and sponsors make their data available for this purpose.
Monthly updates
We regularly make changes to the TherapySelector app. On a monthly basis we import new data.
About TherapySelector
TherapySelector B.V. is a social enterprise. Our mission is to improve health care globally by enriching it with personalized treatment information based on the most recent data from scientific studies. It is not our goal to make profit.
With the TherapySelector app, we facilitate doctors with personalized care to achieve health gains for their patients. Additionally, we want to aid in controlling the rising costs of healthcare for the public, e.g. by preventing over- and under-treatment.
Follow us on LinkedIn (https://www.linkedin.com/company/therapyselector) or visit www.therapyselector.nl.
Show More
